Healthcare -
Biotechnology - NASDAQ - US
$ 1.22
-1.61 %
$ 101 M
Market Cap
-0.48
P/E
EDIT - COST OF REVENUE
Cost of Revenue EDIT - Editas Medicine, Inc.
178 M
LAST VALUE
492.94%
2 YEAR CAGR
14.40%
5 YEAR CAGR
60.26%
10 YEAR CAGR